Evaluation of the safety and efficacy of corifollitropin alfa combined with GnRH agonist triggering in oocyte donation cycles. A prospective longitudinal study.

JBRA Assist Reprod · 2020 · PMC7558885 · PMID 32489086

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

In fact, when donors were asked to choose which treatment they preferred, the results clearly showed a positive trend favoring corifollitropin alfa, suggesting that this new protocol may reduce the treatment burden and increase donor adherence.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.